De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer.
FI: 3,218
Type: Review
Artículo original
Year: 2015
Writers
Madrid-Paredes, A; Canadas-Garre, M; Sanchez-Pozo, A; Calleja-Hernandez, MA
Magazine
Title: PHARMACOGENOMICS
Quartile
- Q2